Technology News and Research

RSS

New nano-sized needle can help study the effects of medicines on cells

Nano-sized needles developed by researchers at the Norwegian University of Science and Technology (NTNU) in Trondheim can force medicine into cells, even when the cell membranes offer resistance. The needles will make it easier to study the effects of medicines on cells.

24 May 2013

New screening method to diagnose breast cancer

A Missouri University of Science and Technology researcher has developed a new screening method that uses urinalysis to diagnose breast cancer - and determine its severity - before it could be detected with a mammogram.

24 May 2013

New approach to genetic engineering reduces time and effort needed to insert genes into bacteria

A new, streamlined approach to genetic engineering drastically reduces the time and effort needed to insert new genes into bacteria, the workhorses of biotechnology, scientists are reporting.

24 May 2013

Economic rewards have a positive effect on blood donations, say researchers

A team of researchers including Johns Hopkins Carey Business School Assistant Professor Mario Macis says the answer is an emphatic yes. Pointing to a large body of recent research that supports their argument, the three economists write in the May 24, 2013, issue of Science that the World Health Organization and national blood collection agencies should reconsider their opposition to economic incentives for much-needed blood donations.

24 May 2013

Algea Therapies introduces SHIELD Vertebral Compression Fracture System

Algea Therapies, a division of Globus Medical Inc. (NYSE: GMED), committed to finding innovative, minimally invasive solutions that treat pain and restore quality of life, today announced the launch of the SHIELD™ Vertebral Compression Fracture (VCF) System, a next generation fracture management and vertebral augmentation platform for patients with vertebral compression fractures.

24 May 2013

3D mammography reduces unnecessary recalls, increases cancer detection

A recently published clinical study conducted at TOPS Comprehensive Breast Center in Houston, Texas, demonstrates that 3D mammography (breast tomosynthesis) significantly reduces unnecessary recalls while simultaneously increasing cancer detection.

24 May 2013

SonaCare Medical highlights need for image-guided technologies to better identify prostate cancer

The need to add tissue preserving therapies to the prostate cancer treatment continuum was highlighted prominently at the 108th Annual Meeting of the American Urological Association, in San Diego.

24 May 2013

Spring Bank Pharmaceuticals starts Phase I study of SB 9200 for treatment of HCV infection

Spring Bank Pharmaceuticals, Inc., a biopharmaceutical company developing innovative medicines for the treatment of viral infections, today announced that it has initiated dosing in a Phase I study of SB 9200, its investigational, once daily, oral therapy for the treatment of HCV infection.

24 May 2013

HealthSouth plans to construct 50-bed inpatient rehabilitation hospital in Georgia

HealthSouth Corporation announced today that it plans to build a 50-bed comprehensive inpatient rehabilitation hospital in Newnan, Ga.

23 May 2013

Cenix BioScience, Debiopharm partner to develop novel therapeutic drug candidates

Cenix BioScience, a leading preclinical contract research provider and technology developer specialized in RNAi-, miRNA- and high content-driven pharmacology, and Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced that they have signed a research agreement to support Debiopharm in its ongoing efforts to develop novel therapeutic drug candidates.

23 May 2013

New drug delivery system can help treat lung cancer

Researchers have developed a new drug delivery system that allows inhalation of chemotherapeutic drugs to help treat lung cancer, and in laboratory and animal tests it appears to reduce the systemic damage done to other organs while significantly improving the treatment of lung tumors.

23 May 2013

Cancer risk to increase following CT scans in younger patients, study reveals

Study leader, Professor John Mathews from the University of Melbourne said this small increase in cancer risk must be weighed against the undoubted benefits from CT scans in diagnosing and monitoring disease.

23 May 2013

REPRISE II trial: Lotus Valve System meets primary endpoint in severe aortic valve disease patients

Boston Scientific Corporation reports positive results from a pre-specified analysis of the first 60 patients enrolled in the REPRISE II trial evaluating the performance and safety of the Lotus™ Valve System in symptomatic patients with severe aortic valve disease considered at high risk for surgical valve replacement.

23 May 2013

IMRIS receives US patent for SYMBIS Surgical System

IMRIS Inc. today announced the allowance of a US patent defining the foundational technologies for its SYMBIS Surgical System - a minimally invasive and MRI-compatible microsurgical robot system.

23 May 2013

Cognoptix' SAPPHIRE II eye test identifies Alzheimer's disease patients via Ab signature in the eyes

Cognoptix, an emerging medical device company, announced today that its SAPPHIRE II eye test identified Alzheimer's disease patients via a beta amyloid ("Ab") signature in their eyes in a 10-subject proof-of-concept clinical trial.

23 May 2013

CardioKinetix reports meta-analysis study results of Parachute Ventricular Partitioning Device

CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced results of a meta-analysis study of the first-of-its-kind catheter-based Parachute Ventricular Partitioning Device. Six-month clinical results from 91 U.S. and European patients with ischemic heart failure were presented at the 2013 EuroPCR Conference in Paris by Dr. Martyn Thomas, M.D., chairman of Cardiology at St. Thomas Hospital in London, England.

23 May 2013

Freedom Innovations officially launches new Kinterra Foot and Ankle System

Freedom Innovations, an Irvine, CA based manufacturer of advanced technology prosthetic devices, has officially launched its new Kinterra Foot and Ankle System, making the technology available to amputees on a global level.

From PROTEOR 23 May 2013

Prosonix commences Phase 2 clinical study of PSX1002 for treatment of moderate to severe COPD

Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, has initiated a Phase 2 clinical study with PSX1002 that will assess its effect on lung function and the safety of a range of doses in patients with moderate to severe chronic obstructive pulmonary disease.

23 May 2013

$Upsher-Smith completes USL255 Phase III clinical trial in patients with refractory POS$

Upsher-Smith completes USL255 Phase III clinical trial in patients with refractory POS

Upsher-Smith Laboratories, Inc. today announced the successful completion of its global Phase III clinical trial for USL255 (extended-release topiramate), an internally developed program for the management of epilepsy in adults, using the company's proprietary formulation technology.

23 May 2013

UC Irvine chemists create new method to identify clinically usable markers for prostate cancer in urine

Early screening for prostate cancer could become as easy for men as personal pregnancy testing is for women, thanks to UC Irvine research published today in the Journal of the American Chemical Society.

23 May 2013

Technology News and Research

New nano-sized needle can help study the effects of medicines on cells

New screening method to diagnose breast cancer

New approach to genetic engineering reduces time and effort needed to insert genes into bacteria

Economic rewards have a positive effect on blood donations, say researchers

Algea Therapies introduces SHIELD Vertebral Compression Fracture System

3D mammography reduces unnecessary recalls, increases cancer detection

SonaCare Medical highlights need for image-guided technologies to better identify prostate cancer

Spring Bank Pharmaceuticals starts Phase I study of SB 9200 for treatment of HCV infection

HealthSouth plans to construct 50-bed inpatient rehabilitation hospital in Georgia

Cenix BioScience, Debiopharm partner to develop novel therapeutic drug candidates

New drug delivery system can help treat lung cancer

Cancer risk to increase following CT scans in younger patients, study reveals

REPRISE II trial: Lotus Valve System meets primary endpoint in severe aortic valve disease patients

IMRIS receives US patent for SYMBIS Surgical System

Cognoptix' SAPPHIRE II eye test identifies Alzheimer's disease patients via Ab signature in the eyes

CardioKinetix reports meta-analysis study results of Parachute Ventricular Partitioning Device

Freedom Innovations officially launches new Kinterra Foot and Ankle System

Prosonix commences Phase 2 clinical study of PSX1002 for treatment of moderate to severe COPD

Upsher-Smith completes USL255 Phase III clinical trial in patients with refractory POS

UC Irvine chemists create new method to identify clinically usable markers for prostate cancer in urine

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News